18.65

6.89% -1.38

After Hours: 18.70 0.05 +0.27%

Pulse Biosciences Inc (PLSE)

Overview News Price History Option Chain Financials Discussions Forecast

Pulse Biosciences Inc stock is traded at $18.65, with a volume of 366.40K. It is down -6.89% in the last 24 hours and down -18.91% over the past month. Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

Previous Close:

$20.03

Open:

$20.04

24h Volume:

366.40K

Relative Volume:

1.03

Market Cap:

$1.27B

Revenue:

$350.00K

Net Income/Loss:

$-72.78M

P/E Ratio:

-17.27

EPS:

-1.08

Net Cash Flow:

$-54.46M

1W Performance:

-14.57%

1M Performance:

-18.91%

6M Performance:

+14.63%

1Y Performance:

+12.42%

1-Day Range:

$18.54

$20.17

1-Week Range:

$18.54

$21.67

52-Week Range:

$12.56

$26.30

Pulse Biosciences Inc Stock (PLSE) Company Profile

Name

Pulse Biosciences Inc

Sector

Healthcare (1106)

Industry

Medical Instruments & Supplies (56)

Phone

510-906-4600

Address

3957 POINT EDEN WAY, HAYWARD, CA

Employee

116

Twitter

@PulseBioNPS

Next Earnings Date

2026-05-14

Latest SEC Filings

PLSE's Discussions on Twitter

Compare PLSE vs ISRG, BDX, MDLN, ALC, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PLSE Pulse Biosciences Inc	18.65	1.37B	350.00K	-72.78M	-54.46M	-1.08
ISRG Intuitive Surgical Inc	451.38	160.21B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	144.17	41.62B	21.92B	1.76B	2.63B	6.1223
MDLN Medline Inc	45.32	37.37B	28.43B	1.16B	1.26B	1.4457
ALC Alcon Inc	74.45	35.82B	10.40B	980.00M	1.61B	1.9749
RMD Resmed Inc	207.88	30.38B	5.40B	1.49B	1.78B	10.12

Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-30-26	Initiated	Mizuho	Outperform
Jul-07-25	Initiated	Oppenheimer	Outperform
Jul-27-21	Initiated	Stephens	Overweight
Mar-11-21	Initiated	Maxim Group	Buy
Jan-26-21	Reiterated	H.C. Wainwright	Buy
May-12-20	Upgrade	H.C. Wainwright	Neutral → Buy
Feb-14-20	Downgrade	H.C. Wainwright	Buy → Neutral
Feb-25-19	Initiated	H.C. Wainwright	Buy

View All

Pulse Biosciences Inc Stock (PLSE) Latest News

Pulse Biosciences Inc (PLSE)

Pulse Biosciences Inc Stock (PLSE) Company Profile

Compare PLSE vs ISRG, BDX, MDLN, ALC, RMD

Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades

Pulse Biosciences Inc Stock (PLSE) Latest News

MSN Money - MSN

Pulse Biosciences (PLSE) Q1 2025 Earnings Transcript - AOL.com

Pulse Biosciences Releases Q1 2026 Financial Results - AlphaStreet

Pulse Biosciences (PLSE) Q1 2025 Earnings Transcript - The Motley Fool

Pulse Biosciences Reports Q1 2026 Financial Results and Business Updates, Highlighting $0.4 Million Revenue from nPulse Vybrance and Clinical Progress 1535 - Minichart

Pulse Biosciences (PLSE) Reports Strong Q1 Performance - GuruFocus

Pulse Biosciences, Inc (PLSE) reports Q1 loss, lags revenue estimates - MSN

Pulse Biosciences 1Q Loss/Shr 27c >PLSE - Moomoo

Pulse Biosciences Highlights Q1 Results, Electrophysiology Focus - TipRanks

Assessing Pulse Biosciences (PLSE) Valuation After Recent Share Price Pullback And Ongoing Losses - Sahm

Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results - BioSpace

Pulse Biosciences, Inc (PLSE) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

Pulse Biosciences Q1 Loss Widens - marketscreener.com

Earnings Flash (PLSE) Pulse Biosciences Posts Q1 Loss $0.27 a Share, vs. FactSet Est of $0.32 Loss - marketscreener.com

Earnings Flash (PLSE) Pulse Biosciences, Inc. Reports Q1 Revenue $401,000, vs. FactSet Est of $250,000 - marketscreener.com

Pulse Biosciences Inc expected to post a loss of 31 cents a shareEarnings Preview - TradingView

BRIEF-Pulse Biosciences Q1 Net Income USD -18.581 Million - TradingView

Pulse Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

Executive pay and 71% insider stake at Pulse Biosciences (NASDAQ: PLSE) - Stock Titan

Pulse Biosciences (PLSE) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Shares Down 7.9%What's Next? - MarketBeat

Pulse Biosciences, Inc. (PLSE) Shareholder/Analyst CallSlideshow (NASDAQ:PLSE) 2026-04-27 - Seeking Alpha

Med-tech companies highlight PFA data as competition intensifies - BioWorld News

Pulse Biosciences Reports Strong nPulse Atrial Fibrillation Data - TipRanks

New nPulse atrial fibrillation data for Pulse Biosciences (NASDAQ: PLSE) - Stock Titan

Pulse Biosciences slips despite Q4 beat after deal to sell shares - MSN

Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026 - BioSpace

How (PLSE) Movements Inform Risk Allocation Models - Stock Traders Daily

Pulse Biosciences (PLSE) Reports Promising Clinical Results for Cardiac Catheter System - GuruFocus

Assessing Pulse Biosciences (PLSE) Valuation After Positive nPulse Cardiac Catheter Study Update - Sahm

Pulse Biosciences Presents Positive Outcomes in Late-Breaking Upd - The National Law Review

Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse Cardiac Catheter System at Heart Rhythm 2026 - Investing News Network

Pulse Biosciences announces positive clinical data from Npulse cardiac catheter system - marketscreener.com

Pulse Biosciences Announces Positive Clinical Data From Npulse Cardiac Catheter System - TradingView

Pulse Biosciences to Host Analyst Event on April 25, 2026 - Investing News Network

PLSE Stock Price, Quote & Chart | PULSE BIOSCIENCES INC (NASDAQ:PLSE) - ChartMill

Pulse Biosciences Trials And Conference Spotlight Reframe Pulse Field Ablation Story - Yahoo Finance

Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference - The National Law Review

Pulse Biosciences' nPulse Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting - Investing News Network

Pulse Biosciences (PLSE) to Showcase Innovations at Heart Rhythm Society 2026 Meeting - GuruFocus

Pulse Biosciences Starts US Trial for Cardiac Catheter System - HarianBasis.co

Pulse Biosciences (PLSE) Enrolls Its First Patients in a Pivotal Atrial Fibrillation Trial - Insider Monkey

Pulse Biosciences’ nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting - ChartMill

Pulse Biosciences' NPulse Technology to Be Featured at the Heart Rhythm Society 2026 Annual Meeting - 富途牛牛

Total debt per share of Pulse Biosciences, Inc. – FWB:6L8 - TradingView

Pulse (PLSE) Stock: Is It Moving in a Trend (Breakout Watch) 2026-04-18Asset Allocation - Xã Vĩnh Công

Pulse Biosciences (NASDAQ:PLSE) Trading 10.1% HigherHere's Why - MarketBeat

Pulse Biosciences Targets Thyroid Nodules With New Device Study, Eyeing a Minimally Invasive Niche - TipRanks

Pulse Biosciences Updates 2026 Cardiac Ablation Strategy - TipRanks

Pulse Biosciences posts updated investor deck with pivotal nsPFA cardiac study details - TradingView

Pulse Biosciences (PLSE) updates investor deck with 2026 clinical goals - Stock Titan

Pulse Biosciences Inc Stock (PLSE) Financials Data

Revenue

Net Income

Cash Flow

EPS

Similar to PLSE